Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 2265Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Leukemia 1500Leukemia, Lymphocytic, Chronic, B-Cell 1120Myelodysplastic Syndromes 963Hematologic Neoplasms 935Lymphoma 739Lymphoma, Non-Hodgkin 654Leukemia, Myelogenous, Chronic, BCR-ABL Positive 532Multiple Myeloma 501Lymphoma, Follicular 467Hodgkin Disease 460Lymphoma, Mantle-Cell 459Burkitt Lymphoma 440Lymphoma, Large B-Cell, Diffuse 433Lymphoma, B-Cell, Marginal Zone 402Recurrence 356Leukemia, Myelomonocytic, Chronic 351Myeloproliferative Disorders 330Leukemia, Myeloid, Chronic-Phase 311Lymphoma, Large-Cell, Immunoblastic 303Congenital Abnormalities 273Neoplasms 271Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Blast Crisis 246Leukemia, Myeloid, Accelerated Phase 244Primary Myelofibrosis 221Neoplasms, Plasma Cell 220Waldenstrom Macroglobulinemia 216Lymphoma, T-Cell, Cutaneous 197

Interventions

transfluthrin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Malaria × Other hematologic neoplasm × Clear all
NCT06179732 2024-04-23

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities

The Mentor Initiative

Phase 3 Completed
2,400 enrolled
LymphoidOther hematologic neoplasm

Vector Borne Diseases, Malaria, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡